A COMPREHENSIVE REVIEW OF A RACE OF VACCINATION AGAINST COVID - 19 VIRUS: THE RECENT VACCINES DEVELOPED
DOI:
https://doi.org/10.37557/gjphm.v3i2.99Keywords:
COVID-19, Vaccines, Viral vector vaccine, mRNA vaccine, Inactivated vaccineAbstract
Vaccines are urgently needed at the present time to protect humanity from COVID-19, which is caused by the Coronavirus 2 that causes severe acute respiratory syndrome. Large quantities of antibodies which have high affinity virus-neutralizing capability were induced by vaccines may optimally prevent infection and avoid unfavourable effects. During the progression of the vaccine, different vaccine models were assessed by disparate groups. This review summarizes the currently approved COVID- 19 vaccines with late-stage clinical results. The currently authorized SARS-CoV-2 vaccines with late stage clinical data are summarized in this review. Thrombosis may be related in some way to the vaccine, but the direct link has not yet been established. It was stressed that the probability of developing strokes is very small and does not compare with the benefit gained from using the vaccine at all.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Maimonah Qasim Yahya, zena sattam hamed , Seema Mahmood Kasim

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain Full copyright of their published article